Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy.

Moreno-Smith M, Lakoma A, Chen Z, Tao L, Scorsone KA, Schild L, Aviles-Padilla K, Nikzad R, Zhang Y, Chakraborty R, Molenaar JJ, Vasudevan SA, Sheehan V, Kim ES, Paust S, Shohet JM, Barbieri E.

Clin Cancer Res. 2017 Nov 1;23(21):6629-6639. doi: 10.1158/1078-0432.CCR-17-0668. Epub 2017 Aug 18.

2.

Heterogeneous Uptake of Nanoparticles in Mouse Models of Pediatric High-Risk Neuroblastoma.

Ghaghada KB, Starosolski ZA, Lakoma A, Kaffes C, Agarwal S, Athreya KK, Shohet J, Kim E, Annapragada A.

PLoS One. 2016 Nov 18;11(11):e0165877. doi: 10.1371/journal.pone.0165877. eCollection 2016.

3.

Transmembrane adaptor protein PAG1 is a novel tumor suppressor in neuroblastoma.

Agarwal S, Ghosh R, Chen Z, Lakoma A, Gunaratne PH, Kim ES, Shohet JM.

Oncotarget. 2016 Apr 26;7(17):24018-26. doi: 10.18632/oncotarget.8116.

4.

G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation.

Agarwal S, Lakoma A, Chen Z, Hicks J, Metelitsa LS, Kim ES, Shohet JM.

Cancer Res. 2015 Jun 15;75(12):2566-79. doi: 10.1158/0008-5472.CAN-14-2946. Epub 2015 Apr 23.

5.

The MDM2 small-molecule inhibitor RG7388 leads to potent tumor inhibition in p53 wild-type neuroblastoma.

Lakoma A, Barbieri E, Agarwal S, Jackson J, Chen Z, Kim Y, McVay M, Shohet JM, Kim ES.

Cell Death Discov. 2015;1. pii: 15026. Epub 2015 Aug 24.

6.

Minimally invasive surgical management of benign breast lesions.

Lakoma A, Kim ES.

Gland Surg. 2014 May;3(2):142-8. doi: 10.3978/j.issn.2227-684X.2014.04.01. Review.

7.

Use of Mitomycin C for Refractory Esophageal Stricture following Tracheoesophageal Fistula Repair.

Lakoma A, Fallon SC, Mathur S, Kim ES.

European J Pediatr Surg Rep. 2013 Jun;1(1):24-6. doi: 10.1055/s-0033-1341418. Epub 2013 Mar 19.

8.

G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic.

Hsu DM, Agarwal S, Benham A, Coarfa C, Trahan DN, Chen Z, Stowers PN, Courtney AN, Lakoma A, Barbieri E, Metelitsa LS, Gunaratne P, Kim ES, Shohet JM.

Cancer Res. 2013 Jul 1;73(13):4134-46. doi: 10.1158/0008-5472.CAN-12-4056. Epub 2013 May 16.

9.

Current readings: surgical repair experience of congenital chest wall deformities.

Lakoma A, Kim ES.

Semin Thorac Cardiovasc Surg. 2013 Winter;25(4):317-22. doi: 10.1053/j.semtcvs.2013.12.001. Epub 2013 Dec 27.

PMID:
24673961
10.

Measurement of pulmonary circulation parameters using time-resolved MR angiography in patients after Ross procedure.

Lakoma A, Tuite D, Sheehan J, Weale P, Carr JC.

AJR Am J Roentgenol. 2010 Apr;194(4):912-9. doi: 10.2214/AJR.09.2897.

PMID:
20308491
11.

Dental and oral radiographic findings in first-year university students in 1982 and 2002 in Helsinki, Finland.

Peltola JS, Ventä I, Haahtela S, Lakoma A, Ylipaavalniemi P, Turtola L.

Acta Odontol Scand. 2006 Feb;64(1):42-6.

PMID:
16428182
12.

Oral piercings among first-year university students.

Ventä I, Lakoma A, Haahtela S, Peltola J, Ylipaavalniemi P, Turtola L.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 May;99(5):546-9.

PMID:
15829875

Supplemental Content

Loading ...
Support Center